Trials / Terminated
TerminatedNCT02349646
A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy
A Post Market Cohort With the Commercially Available Spinal Modulation Neurostimulator System for the Management of Peripheral Neuropathy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
10-SMI-2012 is a post market observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of peripheral neuropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium neurostimulator |
Timeline
- Start date
- 2013-04-25
- Primary completion
- 2016-10-24
- Completion
- 2016-10-24
- First posted
- 2015-01-29
- Last updated
- 2019-10-16
- Results posted
- 2018-06-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02349646. Inclusion in this directory is not an endorsement.